ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Cancer
Leukemia
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near San Diego, CA, USA:

A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma

this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory multiple...

Active, not recruiting
Refractory Multiple Myeloma
Relapsed Multiple Myeloma
Drug: ION251

Phase 1

Ionis Pharmaceuticals
Ionis Pharmaceuticals

La Jolla, California, United States and 5 other locations

This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...

Enrolling
Multiple Myeloma
Drug: Ruxolitinib Oral Tablet [Jakafi]
Drug: Methylprednisolone

Phase 1

Oncotherapeutics

Encinitas, California, United States and 12 other locations

The purpose of this study is to determine the overall response rate of patients with Multiple Myeloma to the combination of Daratum...

Active, not recruiting
Relapsed/Refractory Multiple Myeloma
Drug: Ixazomib
Drug: Dexamethasone

Phase 2

University of California San Diego
University of California San Diego

La Jolla, California, United States of America

progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab SC
Drug: Daratumumab IV

Phase 3

Janssen (J&J Innovative Medicine)

San Diego, California, United States and 211 other locations

versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...

Enrolling
Multiple Myeloma
Drug: Fludarabine
Drug: Daratumumab

Phase 3

Stichting European Myeloma Network

San Diego, California, United States and 126 other locations

with BMS-986405 in participants with relapsed and refractory multiple myeloma (MM). The dose escalation part (Part A) of the study ...

Active, not recruiting
Multiple Myeloma
Drug: CC-99712
Drug: BMS-986405

Phase 1

Celgene
Celgene

La Jolla, California, United States and 19 other locations

The main aims of this study are to test for any side effects from modakafusp alfa in combination therapy and to determine the recommended dose of com...

Active, not recruiting
Multiple Myeloma
Drug: Bortezomib
Drug: Lenalidomide

Phase 1

Takeda
Takeda

San Diego, California, United States and 20 other locations

Phase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in ...

Enrolling
Multiple Myeloma
Drug: Rimiducid
Biological: P-BCMA-ALLO1 CAR-T cells

Phase 1

Poseida Therapeutics

San Diego, California, United States and 13 other locations

Locations recently updated

and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Pomalidomide
Drug: mezigdomide

Phase 3

Celgene
Celgene

San Diego, California, United States and 220 other locations

38 (CD38) treatment naive participants with newly diagnosed multiple myeloma who are MRD positive as determined by next generation...

Active, not recruiting
Multiple Myeloma
Drug: Lenalidomide
Drug: Daratumumab

Phase 3

Janssen (J&J Innovative Medicine)

La Jolla, California, United States and 72 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems